{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:41:06Z","timestamp":1783122066801,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013340","name":"Institute Pasteur De Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013340","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.06.037","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T22:57:22Z","timestamp":1592780242000},"page":"5091-5094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immune response to rabies post-exposure prophylaxis in patients with non-HIV secondary immunodeficiencies"],"prefix":"10.1016","volume":"38","author":[{"given":"Perrine","family":"Parize","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Poujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Morineau Le Houssine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Goesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"Lucet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Basuyau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Cailhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Dacheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Bourhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Henri","family":"Consigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.06.037_b0005","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.2016.16477","article-title":"Prevalence of Immunosuppression Among US Adults, 2013","volume":"316","author":"Harpaz","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.06.037_b0010","unstructured":"2020 Yellow Book Home | Travelers\u2019 Health | CDC [Internet]. [cited 2019 Oct 14]. Available from: https:\/\/wwwnc.cdc.gov\/travel\/page\/yellowbook-home."},{"key":"10.1016\/j.vaccine.2020.06.037_b0015","unstructured":"ACIP Altered Immunocompetence Guidelines for Immunizations | Recommendations | CDC [Internet]. 2019 [cited 2019 Oct 14]. Available from:https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html."},{"key":"10.1016\/j.vaccine.2020.06.037_b0020","unstructured":"World Health Organization, editor. WHO Expert Consultation on Rabies: third report. Geneva, Switzerland: World Health Organization; 2018. 183 p. (WHO technical report series)."},{"key":"10.1016\/j.vaccine.2020.06.037_b0025","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.06.037_b0030","doi-asserted-by":"crossref","first-page":"e1852","DOI":"10.1371\/journal.pntd.0001852","article-title":"Risk of potentially rabid animal exposure among foreign travelers in Southeast Asia","volume":"6","author":"Piyaphanee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.06.037_b0035","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1809.111833","article-title":"Inadequate antibody response to rabies vaccine in immunocompromised patient","volume":"18","author":"Kopel","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.037_b0040","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1016\/j.vaccine.2009.03.027","article-title":"Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus","volume":"27","author":"Sirikwin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.037_b0045","unstructured":"WHO | SAGE meeting of October 2017 [Internet]. WHO. [cited 2019 Oct 14]. Available from: http:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/presentations_background_docs\/en\/."},{"key":"10.1016\/j.vaccine.2020.06.037_b0050","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.037_b0055","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1399-3046.2008.00936.x","article-title":"Immune response to rabies vaccination in pediatric transplant patients","volume":"12","author":"Cramer","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.vaccine.2020.06.037_b0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/tid.12393","article-title":"Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies","volume":"17","author":"Vora","year":"2015","journal-title":"Transpl Infect Dis Off J Transplant Soc"},{"key":"10.1016\/j.vaccine.2020.06.037_b0065","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.vaccine.2004.08.036","article-title":"Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals","volume":"23","author":"Sampath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.037_b0070","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.vaccine.2010.01.003","article-title":"Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients","volume":"28","author":"Tanisaro","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.037_b0075","doi-asserted-by":"crossref","first-page":"e0139171","DOI":"10.1371\/journal.pone.0139171","article-title":"Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions","volume":"10","author":"Rahimi","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2020.06.037_b0080","doi-asserted-by":"crossref","first-page":"1700548","DOI":"10.2807\/1560-7917.ES.2018.23.39.1700548","article-title":"The French Network Of Antirabies Clinics. The shift in rabies epidemiology in France: time to adjust rabies post-exposure risk assessment","volume":"23","author":"Parize","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.06.037_b0085","doi-asserted-by":"crossref","first-page":"e0004920","DOI":"10.1371\/journal.pntd.0004920","article-title":"Persistence of Rabies Virus-Neutralizing Antibodies after Vaccination of Rural Population following Vampire Bat Rabies Outbreak in Brazil","volume":"10","author":"Medeiros","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.06.037_b0090","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.vaccine.2019.08.043","article-title":"Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects","volume":"37","author":"Zhao","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.06.037_b0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1708-8305.2011.00540.x","article-title":"The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule\u2013a case series of 420 travelers","volume":"18","author":"Mills","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.06.037_b0100","unstructured":"World Health Organization. WHO Expert Consultation on Rabies. Second report. World Health Organ Tech Rep Ser 2013;(982):1\u2013139, back cover"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:28Z","timestamp":1759401988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20308239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":20,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20308239"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune response to rabies post-exposure prophylaxis in patients with non-HIV secondary immunodeficiencies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}